Opportunity Information: Apply for PA 12 042
Apply for PA 12 042
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 17, 2015 and posted on Nov 29, 2011.
- Applicants must submit their applications by Mar 17, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments Small businesses City or township governments Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply.Non domestic (non U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R03)" (Funding Opportunity Number PA-12-042) is a National Institutes of Health (NIH) program announcement that supports small, focused research projects aimed at advancing drug abuse and addiction science through international collaboration. The central idea is to fund studies that can move faster or answer questions more effectively by working outside the United States, particularly when another country offers special advantages such as unique scientific expertise, rare or hard-to-reach populations, distinctive data sources, specific environmental conditions, or one-of-a-kind research infrastructure. The work must align with the mission of the National Institute on Drug Abuse (NIDA), and applicants are encouraged, when feasible, to address NIDA scientific priority areas, recognizing that priorities can shift over time.
A key emphasis of the announcement is on leveraging international settings to accelerate discovery in drug abuse and addiction research. This could include collaborations that make use of different policy environments, differing patterns of drug use, varying health system structures, or populations with distinct risk factors and protective factors. The announcement notes that in FY2012, examples of priority topics included research on the linkages between HIV/AIDS and drug abuse, as well as the prevention, initiation, and treatment of nicotine and tobacco use. Within tobacco and nicotine research, there is particular interest in vulnerable or high-risk groups such as children, adolescents, pregnant women, and individuals with co-morbid disorders.
This opportunity uses the NIH R03 mechanism, which is generally intended for smaller-scale projects (often pilot studies, feasibility studies, secondary data analyses, or other narrowly scoped projects that can generate early evidence). The listed award ceiling is $50,000, and the program does not require cost sharing or matching funds. The funding instrument is a grant, and the activity categories are listed under education and health, with the associated CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The opportunity is categorized as discretionary.
Eligibility is broad and includes many types of U.S.-based applicants, such as public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (including small businesses), independent school districts, and various units of local, county, city/township, special district, and state governments. Tribal governments and tribal organizations are also eligible, including federally recognized tribes and other tribal entities. In addition, the announcement explicitly includes a range of institution types and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), regional organizations, faith-based and community-based organizations, and eligible federal agencies. Importantly for an international collaboration program, non-U.S. entities (foreign institutions) may apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed.
The posting date for the opportunity was November 29, 2011. The record shows an original closing date of January 7, 2015, a current closing date of March 17, 2015, and an archive date of April 17, 2015, indicating that this specific listing is no longer open. For full details, applicants were directed to the NIH Grants Guide posting (http://grants.nih.gov/grants/guide/pa-files/PA-12-042.html). For access or technical linking issues, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "International Research Collaboration on Drug Abuse and Addiction Research (R03)".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PA-12-042.
Which federal agency sponsors this program announcement?
This is a National Institutes of Health (NIH) program announcement.
Which NIH institute is most closely associated with the mission focus of this opportunity?
The proposed work must align with the mission of the National Institute on Drug Abuse (NIDA).
What is the main purpose of this opportunity?
The purpose is to support small, focused research projects that advance drug abuse and addiction science through international collaboration, especially when research outside the U.S. can move faster or answer questions more effectively.
Why does this program emphasize conducting research outside the United States?
The announcement emphasizes international settings when another country provides special advantages, such as unique scientific expertise, rare or hard-to-reach populations, distinctive data sources, specific environmental conditions, or one-of-a-kind research infrastructure.
What kinds of international advantages or contexts does the announcement highlight?
Examples include the ability to leverage different policy environments, differing patterns of drug use, varying health system structures, or populations with distinct risk factors and protective factors.
What grant mechanism does this opportunity use?
This opportunity uses the NIH R03 mechanism.
What types of projects are typically appropriate for an NIH R03?
R03 projects are generally smaller in scope and may include pilot studies, feasibility studies, secondary data analyses, or other narrowly scoped projects designed to generate early evidence.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $50,000.
Is cost sharing or matching required?
No. The program states that it does not require cost sharing or matching funds.
What is the funding instrument?
The funding instrument is a grant.
How is this opportunity categorized?
The opportunity is categorized as discretionary, with activity categories listed under education and health.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).
What research areas or priorities are mentioned in the announcement?
The announcement encourages applicants, when feasible, to address NIDA scientific priority areas, noting that priorities can shift over time. It also provides examples of FY2012 priority topics, including linkages between HIV/AIDS and drug abuse and the prevention, initiation, and treatment of nicotine and tobacco use.
Does the opportunity mention specific populations of interest for nicotine and tobacco research?
Yes. Within tobacco and nicotine research, the announcement notes interest in vulnerable or high-risk groups such as children, adolescents, pregnant women, and individuals with co-morbid disorders.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based applicants, such as:
- Public and private institutions of higher education
- Nonprofits (including 501(c)(3) and non-501(c)(3) organizations)
- For-profit organizations (including small businesses)
- Independent school districts
- Units of local, county, city/township, special district, and state governments
- Tribal governments and tribal organizations (including federally recognized tribes and other tribal entities)
- Eligible federal agencies
Are specific institution types and community organizations called out as eligible?
Yes. The announcement explicitly includes organizations and institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), regional organizations, and faith-based and community-based organizations.
Can non-U.S. (foreign) institutions apply?
Yes. The announcement states that non-U.S. entities (foreign institutions) may apply.
Are non-U.S. components of U.S. organizations eligible?
Yes. Non-U.S. components of U.S. organizations are eligible under the announcement.
Are foreign components allowed in applications?
Yes. Foreign components (as defined by NIH policy) are allowed.
When was this opportunity posted?
The posting date shown is November 29, 2011.
What were the closing and archive dates listed for this opportunity?
The record shows an original closing date of January 7, 2015, a current closing date of March 17, 2015, and an archive date of April 17, 2015.
Is this opportunity still open?
No. Based on the listed closing and archive dates, this specific listing is no longer open.
Where can someone find the full official announcement details?
Full details were directed to the NIH Grants Guide posting at:
http://grants.nih.gov/grants/guide/pa-files/PA-12-042.html
Who should be contacted for access or technical linking issues?
For access or technical linking issues, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Limited Competition Competitive Revision for Technology Development within Biomedical Technology Research Centers (P41)
Previous opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 12 042
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 12 042) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Competitive Revision for Technology Development within Biomedical Technology Research Centers (P41) Apply for PAR 12 046 Funding Number: PAR 12 046 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Education Grants Program (R25) Apply for PAR 12 049 Funding Number: PAR 12 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Palliative Care and End of Life in People Living with HIV/AIDS(R01) Apply for RFA NR 12 004 Funding Number: RFA NR 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Palliative Care and End of Life in People Living with HIV/AIDS (R21) Apply for RFA NR 12 005 Funding Number: RFA NR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 12 055 Funding Number: PAR 12 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition The Medical Education Partnership Initiative Linked Awards (MEPI) (R25) Apply for RFA TW 11 004 Funding Number: RFA TW 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| The Chernobyl Tissue Bank Coordinating Center (Limited Competition U24) Apply for RFA CA 12 501 Funding Number: RFA CA 12 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 12 050 Funding Number: PAR 12 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 12 051 Funding Number: PAR 12 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 12 052 Funding Number: PAR 12 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 12 061 Funding Number: PA 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 12 062 Funding Number: PAR 12 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 12 002 Funding Number: RFA CA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 12 003 Funding Number: RFA CA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 12 004 Funding Number: RFA CA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 12 005 Funding Number: RFA CA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NCI Established Investigator Award in Cancer Prevention and Control (K05) Apply for PAR 12 065 Funding Number: PAR 12 065 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Imaging Science Track Award for Research Transition (I/START) R03 Apply for PAR 12 066 Funding Number: PAR 12 066 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Human Health and Heredity in Africa (H3Africa) Research Grants (U01) Apply for RFA RM 12 004 Funding Number: RFA RM 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 12 035 Funding Number: PAR 12 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 12 042", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.